1. Home
  2. ZLAB vs SONO Comparison

ZLAB vs SONO Comparison

Compare ZLAB & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SONO
  • Stock Information
  • Founded
  • ZLAB 2013
  • SONO 2002
  • Country
  • ZLAB China
  • SONO United States
  • Employees
  • ZLAB N/A
  • SONO N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SONO Consumer Electronics/Video Chains
  • Sector
  • ZLAB Health Care
  • SONO Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • SONO Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • SONO 1.2B
  • IPO Year
  • ZLAB 2017
  • SONO 2018
  • Fundamental
  • Price
  • ZLAB $32.54
  • SONO $10.67
  • Analyst Decision
  • ZLAB Buy
  • SONO Buy
  • Analyst Count
  • ZLAB 5
  • SONO 3
  • Target Price
  • ZLAB $54.28
  • SONO $13.00
  • AVG Volume (30 Days)
  • ZLAB 781.8K
  • SONO 1.6M
  • Earning Date
  • ZLAB 08-05-2025
  • SONO 08-06-2025
  • Dividend Yield
  • ZLAB N/A
  • SONO N/A
  • EPS Growth
  • ZLAB N/A
  • SONO N/A
  • EPS
  • ZLAB N/A
  • SONO N/A
  • Revenue
  • ZLAB $418,326,000.00
  • SONO $1,463,138,000.00
  • Revenue This Year
  • ZLAB $44.07
  • SONO N/A
  • Revenue Next Year
  • ZLAB $49.13
  • SONO $3.27
  • P/E Ratio
  • ZLAB N/A
  • SONO N/A
  • Revenue Growth
  • ZLAB 43.72
  • SONO N/A
  • 52 Week Low
  • ZLAB $16.01
  • SONO $7.63
  • 52 Week High
  • ZLAB $44.34
  • SONO $15.89
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • SONO 51.73
  • Support Level
  • ZLAB $34.26
  • SONO $10.56
  • Resistance Level
  • ZLAB $35.72
  • SONO $11.12
  • Average True Range (ATR)
  • ZLAB 1.12
  • SONO 0.38
  • MACD
  • ZLAB -0.54
  • SONO 0.01
  • Stochastic Oscillator
  • ZLAB 3.83
  • SONO 58.62

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SONO Sonos Inc.

Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa and the Asia Pacific. Generating a majority of its revenue from the Americas.

Share on Social Networks: